GGenpact LTD

NYSE genpact.com


$ 39.02 $ 0.27 (0.7 %)    

Wednesday, 21-Aug-2024 15:59:58 EDT
QQQ $ 482.88 $ 1.76 (0.37 %)
DIA $ 408.91 $ -0.32 (-0.08 %)
SPY $ 560.81 $ 0.88 (0.16 %)
TLT $ 98.72 $ 0.04 (0.04 %)
GLD $ 232.16 $ 0.50 (0.22 %)
$ 39.02
$ 38.69
$ 39.02 x 300
-- x --
$ 38.69 - $ 39.12
$ 29.03 - $ 39.12
774,733
na
7.01B
$ 1.04
$ 10.82
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-09-2024 06-30-2024 10-Q
2 05-10-2024 03-31-2024 10-Q
3 02-29-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-10-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-09-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 03-01-2022 12-31-2021 10-K
12 11-09-2021 09-30-2021 10-Q
13 08-09-2021 06-30-2021 10-Q
14 05-10-2021 03-31-2021 10-Q
15 03-01-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-11-2020 03-31-2020 10-Q
19 03-02-2020 12-31-2019 10-K
20 11-08-2019 09-30-2019 10-Q
21 08-09-2019 06-30-2019 10-Q
22 05-10-2019 03-31-2019 10-Q
23 03-01-2019 12-31-2018 10-K
24 11-09-2018 09-30-2018 10-Q
25 08-09-2018 06-30-2018 10-Q
26 05-10-2018 03-31-2018 10-Q
27 03-01-2018 12-31-2017 10-K
28 11-09-2017 09-30-2017 10-Q
29 08-09-2017 06-30-2017 10-Q
30 05-10-2017 03-31-2017 10-Q
31 03-01-2017 12-31-2016 10-K
32 11-08-2016 09-30-2016 10-Q
33 08-08-2016 06-30-2016 10-Q
34 05-09-2016 03-31-2016 10-Q
35 02-26-2016 12-31-2015 10-K
36 11-06-2015 09-30-2015 10-Q
37 08-07-2015 06-30-2015 10-Q
38 05-08-2015 03-31-2015 10-Q
39 02-27-2015 12-31-2014 10-K
40 11-07-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 bmo-capital-maintains-market-perform-on-genpact-raises-price-target-to-42

BMO Capital analyst Keith Bachman maintains Genpact (NYSE:G) with a Market Perform and raises the price target from $38 to $42.

 td-cowen-maintains-hold-on-genpact-raises-price-target-to-36

TD Cowen analyst Bryan Bergin maintains Genpact (NYSE:G) with a Hold and raises the price target from $35 to $36.

 needham-maintains-buy-on-genpact-raises-price-target-to-42

Needham analyst Mayank Tandon maintains Genpact (NYSE:G) with a Buy and raises the price target from $40 to $42.

 genpact-sees-q3-revenue-118b-1186b-vs-116b-est-raises-fy24-eps-from-301-304-to-314-318-vs-303-est-revenue-4656b-4701b-vs-462b-est

OutlookGenpact's outlook for the third quarter of 2024 is as follows:Total revenue in the range of $1.180 billion to $1.186...

 genpact-q2-adj-079-beats-072-estimate-sales-118b-beat-114b-estimate

Genpact (NYSE:G) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.72 by 9.72 perc...

 how-to-earn-500-a-month-from-genpact-stock-ahead-of-q2-earnings-report

Genpact Limited (NYSE: G) is expected to report 2Q earnings of 72 cents per share and $1.14 billion in revenue. It offers a 1.8...

Core News & Articles

Genpact's deep domain knowledge and data expertise enables embecta's vision to make a meaningful impact in the healthca...

 magnificent-7-still-comprise-over-30-of-sp-500-despite-tech-correction

Market rebalancing away from large tech companies, but the Magnificent 7 still make up outsized portion of S&P 500.

 jp-morgan-upgrades-genpact-to-neutral-lowers-price-target-to-40

JP Morgan analyst Tien-Tsin Huang upgrades Genpact (NYSE:G) from Underweight to Neutral and lowers the price target from $43...

 tracelink-partners-with-genpact-to-enhance-digital-supply-chain-solutions-for-healthcare-and-life-sciences-sectors

Combining Advanced Technology And AI Expertise To Improve Cost, Service, Predictability, And Resiliency Across Supply Chains

 stocks-pause-on-dismal-consumer-confidence-yields-dollar-rise-as-inflation-expectations-kick-higher-bitcoin-sinks-whats-driving-markets-friday-corrected

Editor’s note: This story has been updated to correct an error in the price action of Charter Communications stock.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION